For instance, ERK-mediated mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) expression is involved in cisplatin resistance, and thus, its targeting could potentially overcome cisplatin resistance in patients with ovarian cancer [6]. The gene discussed is MAPK1; the disease is ovarian cancer.